Vaxart, Inc.
VXRT- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000072444
No open-market purchases or sales by Vaxart, Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $39.0K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Vaxart, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 5 | 4 | −1 |
| Shares | 56.7K | 64.7K | +7.96K (+14.0%) |
| Value | $34.2K | $39.0K | +$4.82K (+14.1%) |
New holders (1)
Institutions that held Vaxart, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kingswood Wealth Advisors, LLC | 10,005 | $6.05K | 0.00% |
Sold out (2)
Institutions that held Vaxart, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Golden State Equity Partners | 2,000 | $1.21K |
| First Command Advisory Services, Inc. | 40 | $24 |